FDA Approves Unknown Drug — RISING

# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals has received FDA approval for ANDA200217, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceuticals sector. The approval enables Rising to introduce a cost-effective therapeutic alternative to the market, potentially driving price competition and increasing accessibility for patients while supporting the company's growth strategy in the generic drug space.